Quantum Cyber N.V. Cash And Cash Equivalents
Quantum Cyber N.V. (QUCY) had Cash And Cash Equivalents of $1.91 million as of 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
ifrs-full:CashAndCashEquivalents · last filed 2025-09-26
- 2025-06-30: Cash And Cash Equivalents $1.91M.
- 2024-12-31: Cash And Cash Equivalents $6.24M.
- 2024-06-30: Cash And Cash Equivalents $977.76K.
- 2023-12-31: Cash And Cash Equivalents $7.07M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-06-30 | $1.91M 6-K · filed 2025-09-26 |
| 2024-12-31 | $6.24M 6-K · filed 2025-09-26 |
| 2024-06-30 | $977.76K 6-K · filed 2025-09-26 |
| 2023-12-31 | $7.07M 6-K · filed 2025-09-26 |
| 2023-09-30 | $9.32M 6-K · filed 2023-11-16 |
| 2023-06-30 | $10.91M 6-K · filed 2024-10-18 |
| 2023-03-31 | $10.86M 6-K · filed 2023-05-16 |
| 2022-12-31 | $17.14M 20-F · filed 2025-03-31 |
| 2022-09-30 | $22.01M 6-K · filed 2023-11-16 |
| 2022-06-30 | $26.01M 6-K · filed 2023-08-15 |
| 2022-03-31 | $29.97M 6-K · filed 2023-05-16 |
| 2021-12-31 | $8.73M 20-F · filed 2025-03-31 |
| 2021-06-30 | $195.16K 6-K · filed 2022-09-07 |
| 2020-12-31 | $122.57K 20-F · filed 2024-04-09 |
| 2019-12-31 | $203.59K 20-F · filed 2023-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |